Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Furth

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Nature Genetics|June 30, 2001
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesisX Xu, W Qiao, S P Linke, et al.
Oncogene|July 27, 2007
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancerL P Jones, M T Tilli, S Assefnia, et al.
Neoplasia (New York, N.Y.)|August 23, 2019
Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast CancerF R Saenz, V Ory, M O Schmidt, et al.
Nucleic Acids Research|October 23, 1997
Cre-mediated gene deletion in the mammary glandK U Wagner, R J Wall, L St-Onge, et al.
Cancer Research|June 11, 1999
Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivoK Schorr, M Li, U Bar-Peled, et al.
Oncogene|July 16, 2013
The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situV Ory, E Tassi, L R Cavalli, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Nature Genetics|June 30, 2001
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesisX Xu, W Qiao, S P Linke, et al.
Oncogene|July 27, 2007
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancerL P Jones, M T Tilli, S Assefnia, et al.
Neoplasia (New York, N.Y.)|August 23, 2019
Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast CancerF R Saenz, V Ory, M O Schmidt, et al.
Nucleic Acids Research|October 23, 1997
Cre-mediated gene deletion in the mammary glandK U Wagner, R J Wall, L St-Onge, et al.
Cancer Research|June 11, 1999
Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivoK Schorr, M Li, U Bar-Peled, et al.
Oncogene|July 16, 2013
The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situV Ory, E Tassi, L R Cavalli, et al.
Pageof 6